Rare Diseases and Mondo
The Global Challenge of Rare Diseases
An estimated 300 million people worldwide—nearly 4% of the global population—are affected by a rare disease. Despite this enormous collective impact, the majority of rare conditions have only a handful of recorded cases. This limited representation means there is often scarce information about symptoms, causes, and disease progression, leading many patients through a “diagnostic odyssey” of incorrect diagnoses, unnecessary tests, and delayed care.
Consider fibrodysplasia ossificans progressiva (FOP), also known as “Stoneman syndrome” (MONDO:0007606): with an estimated prevalence of 1 in 2 million and only about 700 reported cases worldwide, FOP patients endure a high rate of initial misdiagnosis (87%), with many undergoing unnecessary biopsies (67%) and receiving inappropriate therapies (68%) (PMID:31785620, PMID:16230464).
Mondo brings together the world’s rare disease resources to help shorten the diagnostic odysseys.
What Makes a Disease “Rare”?
There is no universal definition of “rare disease.” The concept is typically defined by prevalence—the number of affected individuals per population—but these thresholds vary significantly PMID:39261914:
| Region | Prevalence Threshold | Equivalent |
|---|---|---|
| United States | Fewer than 200,000 people | ~1 in 1,500 |
| European Union | Fewer than 1 in 2,000 | ~250,000 |
| Japan | Fewer than 1 in 2,500 | ~50,000 |
Beyond different thresholds, disease prevalence itself varies by geography. For example, Kawasaki disease affects approximately 1 in 6,500-20,500 children under 5 in Europe (considered “rare”), but 1 in 324 in Japan (considered “common”)(PMID:22307434, PMID:30786118).
Some organizations also require additional criteria, such as the disease being “life-threatening or chronically debilitating” (EU Orphan Drug Regulation (EC No 141/2000)).
Why This Matters
These differences have real consequences:
- Research funding: Programs like the FDA’s Orphan Drug Designation provide incentives only for diseases classified as “rare”
- Insurance coverage: Whether a disease is designated “rare” can affect treatment coverage
- Clinical trials: Rare disease status influences eligibility for specialized trial pathways
- Patient advocacy: Organizations focus resources based on rare disease classifications
How Mondo Handles Rare Diseases
Rather than imposing a single definition of “rare,” Mondo takes a pragmatic, inclusive approach:
Mondo integrates rare disease information from multiple authoritative sources and transparently tracks which sources consider each disease to be rare.
This means:
- ✅ You can access all diseases considered rare by any major authority
- ✅ You can filter to diseases considered rare by specific authorities relevant to your region or use case
- ✅ You always know the provenance of the “rare” designation
Sources of Rare Disease Information in Mondo
| Source | What it provides | Subset annotation |
|---|---|---|
| Orphanet | European reference for rare diseases; comprehensive disease descriptions, diagnostic tests, orphan drug data | orphanet_rare |
| GARD | NIH’s Genetic and Rare Diseases Information Center; patient-friendly information for US audiences | gard_rare |
| NORD | National Organization for Rare Disorders; patient advocacy, education, and research support | nord_rare |
| Literature | Diseases reported as rare in peer-reviewed publications but not yet in authoritative lists | mondo_rare |
| Ontology inference | Children of rare disease terms inherit the “rare” designation | inferred_rare |
Understanding the Overlap
Not all sources agree on which diseases are rare. Our analysis shows:
- Only ~35% of diseases in Mondo’s rare subset are considered rare by all authoritative sources
- ~40% are recognized by Orphanet
- Different sources use different criteria for what counts as a distinct “rare disease” (e.g., Orphanet counts only “disorders,” while NORD and GARD also count disease subtypes)
This reflects genuine scientific and policy disagreement—not a problem to solve, but a reality to represent accurately.
Finding Rare Diseases in Mondo
For Patients and Advocates
If you’re looking for information about a specific rare disease:
- Search on Monarch Initiative: Visit monarchinitiative.org and search for your disease
- Follow links to authoritative sources: Each Mondo term links to original sources (Orphanet, GARD, NORD, OMIM, etc.) for detailed information
For Researchers and Developers
Download the Rare Disease Subset
The Mondo rare disease subset includes all diseases considered rare by at least one authoritative source:
| Format | Download Link |
|---|---|
| OBO | mondo-rare.obo |
| JSON | mondo-rare.json |
Filter by Source
To get rare diseases according to a specific authority, filter by the in_subset annotation:
# Example: Get only Orphanet rare diseases
Filter where in_subset contains "orphanet_rare"
# Example: Get diseases rare in the US (GARD or NORD)
Filter where in_subset contains "gard_rare" OR "nord_rare"
Understanding Subset Annotations
Each rare disease term in Mondo has:
rare: Present on ALL terms in the rare disease subset (union of all sources)orphanet_rare,gard_rare,nord_rare: Indicates the specific authoritymondo_rare: Manually curated from literature (community-reported)inferred_rare: Inherited from a parent term that is rarerare_grouping: Parent terms included for classification context (not themselves rare diseases)
Example: Calciphylaxis (MONDO:0017215) is annotated with nord_rare, gard_rare, and orphanet_rare—indicating consensus across all three authorities.
Real-World Applications
COVID-19 and Rare Disease Research
The National COVID Cohort Collaborative (N3C) used Mondo to study outcomes for rare disease patients during the pandemic:
- Imported Mondo’s KGX format into the N3C research enclave
- Selected terms with the “rare” designation
- Leveraged Mondo’s mappings to clinical codes (SNOMED, ICD-10, MeSH) to identify patients
- Created a rare disease dashboard enabling researchers to explore rare disease cohorts
Diagnostic Tools
Tools like Exomiser use Mondo’s rare disease classifications alongside phenotype data to help clinicians navigate diagnostic odysseys and identify potentially pathogenic variants.
Drug Repurposing
Mondo’s integration of rare diseases with broader disease classifications enables researchers to identify common biological pathways between rare and common diseases—opening opportunities for drug repurposing. Every Cure, for example, is using Mondo as the backbone for their drug-disease research.
How Rare Disease Data is Maintained
Mondo maintains rare disease annotations through automated pipelines that synchronize monthly with authoritative sources:
- GARD and NORD: Partner organizations maintain spreadsheets with Mondo IDs; automated workflows update Mondo accordingly
- Orphanet: Automated integration from Orphanet’s published data files
- Community curation: Researchers can report rare diseases not yet in authoritative lists via GitHub issues
This system ensures:
- Authoritative sources remain the “source of truth”
- Updates propagate to Mondo within one month
- Full transparency about data provenance
When Terms Change
If a Mondo term is obsoleted
The term will not appear in the rare disease subset. The relevant authoritative source(s) will be notified.
If a source removes a disease from their rare list
Only that source’s annotation is removed (e.g., gard_rare). Other source annotations remain unchanged.
If two Mondo terms are merged
Rare disease annotations will be transferred to the surviving term as soon as the update is made at the authoritative source.
Get Involved
Report a Missing Rare Disease
If you know of a rare disease not represented in Mondo or missing from the rare disease subset, please open a GitHub issue.
Connect with Rare Disease Communities
Mondo works closely with rare disease organizations worldwide. Contact us to discuss collaboration opportunities.
Rare Disease Day
Join us in recognizing Rare Disease Day on the last day of February each year, raising awareness for the 300 million people living with rare diseases worldwide.
Quick Reference
| I want to… | Action |
|---|---|
| Find if my disease is considered rare | Search on Monarch Initiative and check subset annotations |
| Download all rare diseases | Get mondo-rare.obo or mondo-rare.json |
| Get rare diseases for a specific region | Filter by orphanet_rare (Europe), gard_rare or nord_rare (US) |
| Report a missing rare disease | Open a GitHub issue |
| Learn more about a specific rare disease | Follow cross-references to OMIM, Orphanet, GARD, or NORD |